Novalis Biotech Incubation, a Belgian seed-stage biotech investor, is fundraising for a second, €25m investment vehicle, according to co-founder and managing director Jan Van den Berghe.
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Company will operate with the GP's existing test and measurement companies in the US and Denmark
Numerous Italian GPs with a generalist approach have reshaped their activity towards the tech sector
GP plans to merge Atlantic with portfolio company Maced, in which it acquired a majority stake last year